Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.
Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.
The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.
On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.
Morgan Stanley Finance LLC offers $10,317,000 aggregate principal of Trigger PLUS principal‑at‑risk securities due March 7, 2031, fully and unconditionally guaranteed by Morgan Stanley.
The notes are linked to the worst performing of the Russell 1000® and S&P 500® indices, pay no interest, return principal at maturity only if the worst performing underlier finishes at or above its 75% downside threshold, provide a leveraged upside equal to 118.32% of appreciation of the worst performing underlier, and otherwise expose investors to a pro rata loss of principal (1% loss for each 1% decline in the worst performing underlier). The issue price is $1,000 per security and the estimated value on pricing date was $980.20 per security.
Morgan Stanley Finance LLC priced a structured, principal‑at‑risk note program totaling $585,000 aggregate. The securities are unsecured obligations of MSFL and are fully and unconditionally guaranteed by Morgan Stanley, issue price $1,000 per security and estimated value $895.50 on pricing date.
The notes pay a contingent coupon at an annual rate of 8.00% on each coupon payment date only if the underlier meets the coupon barrier; they feature automatic early redemption if the underlier is at or above the call threshold and mature on March 7, 2031 with principal at risk. Coupon barrier and downside threshold are 1,354.38 (50% of the initial level); call threshold is 2,248.271 (~83% of initial). Investors may lose all or a substantial portion of principal.
Morgan Stanley Finance LLC priced contingent income auto-callable securities linked to NVIDIA Corporation common stock. The securities: stated principal $1,000 each, aggregate $1,626,000, issue price $1,000, estimated value $957.50. They mature on March 8, 2029 with a final observation date of March 5, 2029.
The notes pay a contingent coupon at an annual rate of 12.65% only if the closing level on each observation date is at or above the coupon barrier of $109.824 (60% of the initial level). They are automatically redeemed if NVIDIA’s closing level equals or exceeds the call threshold of $183.04 (100% of the initial level) on a redemption determination date. If not auto-redeemed, maturity payment depends on the final level versus the downside threshold of $91.52 (50% of the initial level), and losses can equal the full decline in the underlier.
Morgan Stanley Finance LLC issues Principal-at-Risk notes — contingent income auto-callable securities due March 7, 2031, fully and unconditionally guaranteed by Morgan Stanley. The offering comprises $668,000 aggregate principal at $1,000 per security with an estimated value of $936.90 on the pricing date.
The securities pay a contingent annual coupon of 8.40% on each coupon date only if both underliers meet coupon barrier levels; automatic early redemption may occur beginning on March 4, 2027. If not called, principal repayment at maturity depends on the worst-performing underlier (Nasdaq-100® Technology Sector and Russell 2000®), with a downside threshold at ~75% of each initial level, exposing investors to potential full loss of principal.
Morgan Stanley Finance LLC issues a March 2026 preliminary pricing supplement for market‑linked, auto‑callable principal‑at‑risk securities guaranteed by Morgan Stanley. The securities have a public offering price of $1,000 per security, agent commissions of $25.75 per security and estimated value on the pricing date of $902.70. The securities are linked to the lowest performing of Broadcom, Alphabet (Class A) and Netflix, include an automatic call feature with a $1,500 call payment, a participation rate of at least 400% (to be set on the pricing date), and a maturity date of March 16, 2029 (subject to postponement).
Morgan Stanley Finance LLC is offering Principal at Risk Securities (PLUS) due March 22, 2030, fully and unconditionally guaranteed by Morgan Stanley. Each note has a $1,000 stated principal amount and an issue price of $1,000. The payoff is linked to the worst performing of the Invesco S&P 500® Equal Weight ETF (RSP) and the Nasdaq-100 Index® (NDX) measured from the strike date March 19, 2026 to the observation date March 19, 2030. If the worst performing underlier finishes above its initial level, investors receive the stated principal plus a 200% leverage of that appreciation, capped at a maximum payment of $1,957.50 per security (195.75% of principal). If either underlier is at or below its initial level at observation, the payment equals the stated principal multiplied by the worst performing underlier’s performance factor, and investors may lose up to their entire principal. The estimated value on the pricing date is approximately $978.20 per security.
Morgan Stanley Finance LLC is offering contingent income, auto-callable principal‑at‑risk notes linked to NVIDIA Corporation common stock, fully and unconditionally guaranteed by Morgan Stanley. Each security has a stated principal amount of $1,000, a contingent coupon at an annual rate of 15.25%, a maturity date of April 23, 2027, and a final observation date of April 20, 2027. The notes pay the contingent coupon only if the closing level of NVIDIA is at or above the coupon barrier (57% of the initial level) on each observation date, and are automatically redeemed early if NVIDIA’s closing level meets or exceeds the call threshold (100% of the initial level) on any redemption determination date. At maturity, if the final level is below the downside threshold (58% of the initial level), investors suffer principal losses pro rata to the decline in the underlier; if the final level is at or above that threshold, investors receive the stated principal. All payments are subject to Morgan Stanley’s credit risk.
Morgan Stanley Finance LLC is offering auto-callable, principal-at-risk structured notes linked to the worst performing of Broadcom Inc. (AVGO) and Meta Platforms, Inc. (META). Each security has a stated principal amount of $1,000, an original issue date of March 20, 2026 and a maturity date of March 22, 2029.
The notes may be automatically redeemed on scheduled determination dates, with early redemption payments of $1,300 on March 23, 2027 and $1,600 on March 22, 2028 if both underliers meet call thresholds. If not called, maturity payments range from $1,900 (if both meet call thresholds) to an amount that reflects the performance factor of the worst performing underlier, with downside thresholds at 50% of initial levels. The document states an estimated value on the pricing date of approximately $936.20 per security and notes that all payments are subject to Morgan Stanley’s credit risk.
Morgan Stanley Finance LLC is offering structured, principal-at-risk notes due March 22, 2029 linked to the worst performing of UnitedHealth (UNH), Eli Lilly (LLY) and Johnson & Johnson (JNJ). Each security has a $1,000 stated principal amount and an issue price of $1,000. The estimated value on the pricing date is approximately $928.70. The notes feature an automatic early redemption on March 23, 2027 if each underlier meets its call threshold, payable $1,720 per security on that date. If not redeemed, maturity payments depend on the worst performing underlier: investors may receive the principal plus an upside payment (participation rate 300%) if all final levels exceed initial levels, receive only principal if final levels stay above downside thresholds (50% of initial levels), or suffer losses proportional to the decline of the worst performing underlier (potentially losing the entire principal).
Morgan Stanley Finance LLC is offering Structured Investments—Principal at Risk securities (Buffered Jump Securities with an Auto-Callable feature) linked to the S&P 500® Index.
Each security has a $1,000 stated principal amount, an estimated value on the pricing date of approximately $957.50, a 10% buffer level (90% of the initial level), a minimum payment at maturity of 10% of principal, and a final maturity date of March 21, 2031. Automatic early redemption may occur on set determination dates beginning March 25, 2027, with fixed early redemption payments equivalent to approximately 6.80% per annum (example payments: $1,068; $1,136; $1,204; $1,272). The securities do not pay interest and are subject to Morgan Stanley's credit risk and other risks described herein.